Actinium Pharmaceuticals shares owned by Jpmorgan Chase & Co
Quarter-by-quarter ownership of Actinium Pharmaceuticals (ATNM) shares owned by Jpmorgan Chase & Co
from 13F filings
Historical chart of Jpmorgan Chase & Co investment in Actinium Pharmaceuticals
Tip: Access up to 7 years of quarterly data
All positions including Actinium Pharmaceuticals held by Jpmorgan Chase & Co consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Actinium Pharmaceuticals by Jpmorgan Chase & Co
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $2.5k | 1.6k | 1.60 |
| 2025-03-31 | $34k | 21k | 1.61 |
| 2024-12-31 | $156k | 124k | 1.26 |
| 2024-09-30 | $26k | 14k | 1.88 |
| 2024-06-30 | $103k | 14k | 7.40 |
| 2024-03-31 | $92k | 12k | 7.83 |
| 2023-12-31 | $94k | 19k | 5.08 |
| 2023-09-30 | $107k | 18k | 5.92 |
| 2023-06-30 | $150k | 20k | 7.42 |